Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Thyroid ; 26(3): 404-13, 2016 03.
Article in English | MEDLINE | ID: mdl-26541309

ABSTRACT

BACKGROUND: This study aimed to analyze the temporal changes of the clinicopathologic characteristics, and the long-term outcomes, of various types of anaplastic thyroid cancer (ATC) and poorly differentiated thyroid cancer (PDTC). METHODS: A retrospective analysis was conducted on patients with ATC and PDTC who were treated from 1985 to 2013. The outcome measures included the clinical response to treatment and the survival rates of three separate thyroid cancer groups: ATC, PDTC, and differentiated thyroid cancer (DTC) with anaplastic foci. RESULTS: The five-year disease-specific survival rate was significantly higher, both in DTC with anaplastic foci and in PTDC (81.3% and 65.8%, respectively), than it was in ATC (14.3%; p < 0.001). The proportion of cases of DTC with anaplastic foci has been increasing over time, while that of ATC has decreased. The survival rate was found to be significantly higher in resectable tumors (71.4% and 26.5%, respectively; p < 0 .001). In ATC, external beam radiation therapy showed longer survival rates than did surgery-based treatment in unresectable tumors (19.2 vs. 7.7 months, p = 0.006). Adjuvant treatment with external beam radiation or radioactive iodine increased survival duration in PDTC and in DTC with anaplastic foci. Lymphatic invasion was the most significant postoperative prognosticator in ATC (p = 0.013). CONCLUSIONS: The choice of treatment of ATC and PDTC could be modified according to resectability and lymphatic invasion of the cancer.


Subject(s)
Carcinoma/pathology , Cell Differentiation , Iodine Radioisotopes/therapeutic use , Radiopharmaceuticals/therapeutic use , Thyroid Carcinoma, Anaplastic/therapy , Thyroid Neoplasms/therapy , Thyroidectomy , Adult , Aged , Carcinoma/mortality , Carcinoma/therapy , Chemotherapy, Adjuvant , Female , Humans , Incidence , Iodine Radioisotopes/adverse effects , Lymphatic Vessels/pathology , Male , Middle Aged , Neoplasm Invasiveness , Proportional Hazards Models , Radiopharmaceuticals/adverse effects , Radiotherapy, Adjuvant , Republic of Korea/epidemiology , Retrospective Studies , Risk Factors , Thyroid Carcinoma, Anaplastic/mortality , Thyroid Carcinoma, Anaplastic/pathology , Thyroid Neoplasms/mortality , Thyroid Neoplasms/pathology , Thyroidectomy/adverse effects , Thyroidectomy/mortality , Time Factors , Treatment Outcome
2.
Clin Exp Otorhinolaryngol ; 6(1): 52-5, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23526730

ABSTRACT

Mandibular metastasis of thyroid carcinoma is extremely rare. We present the case of a 46-year-old woman who had bilateral huge cheek masses that had grown rapidly over several years. Intra-oral mucosal tissue biopsy and imaging work-up including computed tomography scan and magnetic resonance imaging were performed and the initial diagnosis was presumed to be central giant cell granuloma. Incidentally detected thyroid lesions were studied with ultra-sonography guided fine needle aspiration and diagnosed as simple benign nodules. Due to continuous oral bleeding and the locally destructive feature of the lesions, we decided to excise the mass surgically. To avoid functional deficit, a stepwise approach was performed: Firstly, the larger left mass was excised and the mandible was reconstructed with a fibular free flap. The final pathologic diagnosis was follicular thyroid cancer. Postoperative I-131 thyroid scan and whole body positron-emissions-tomography were performed. Right side mass was revealed as a thyroid malignancy. Multiple bony metastases were detected. Since further radioactive iodine therapy was required, additional total thyroidectomy and right side mandibulectomy with fibular free flap reconstruction was performed. The patient also underwent high dose radioactive iodine therapy and palliative extra-beam radiotherapy for the metastatic lumbar lesion. Follicular thyroid carcinoma should be considered as a differential diagnosis for mandibular mass lesions.

3.
J Sci Food Agric ; 93(3): 587-92, 2013 Feb.
Article in English | MEDLINE | ID: mdl-22903784

ABSTRACT

BACKGROUND: The increase in drug-resistant bacteria and the ban on antibiotic growth promoters worldwide make the search for novel means of preventing bacterial infection and promoting growth performance imperative. In this sense, antimicrobial peptides are thought to be ideal candidates owing to their antimicrobial properties, broad spectrum of activity and low propensity for development of bacterial resistance. The aim of the present study was to investigate the effect of dietary supplementation with antimicrobial peptide-P5 (AMP-P5) on weanling pig nutrition. RESULTS: A total of 240 weanling pigs were allotted to four treatments on the basis of initial body weight. There were four replicates in each treatment, with 15 pigs per replicate. Dietary treatments were negative control (NC, basal diet without antimicrobial), positive control (PC, basal diet + 1.5 g kg(-1) apramycin), basal diet with 40 mg kg(-1) AMP-P5 (P5-40) and basal diet with 60 mg kg(-1) AMP-P5 (P5-60). Pigs fed the PC or P5-60 diet showed improved (P < 0.05) overall growth performance, apparent total tract digestibility of dry matter, crude protein and gross energy and reduced (P < 0.05) faecal and intestinal coliforms compared with pigs fed the NC diet. CONCLUSION: The results obtained in this study indicate that dietary supplementation with 60 mg kg(-1) AMP-P5 has the potential to improve the growth performance and apparent total tract digestibility of nutrients and reduce coliforms in weanling pigs.


Subject(s)
Anti-Infective Agents/administration & dosage , Antimicrobial Cationic Peptides/administration & dosage , Digestion/drug effects , Feces/microbiology , Intestines/microbiology , Sus scrofa/growth & development , Animals , Antimicrobial Cationic Peptides/chemistry , Dietary Supplements , Intestinal Mucosa/metabolism , Intestines/anatomy & histology , Peptides/administration & dosage , Sus scrofa/metabolism , Sus scrofa/microbiology , Weaning
4.
Head Neck ; 30(3): 346-50, 2008 Mar.
Article in English | MEDLINE | ID: mdl-17972310

ABSTRACT

BACKGROUND: Although meta-analysis showed that survival improved with concurrent chemoradiation in locally advanced head and neck cancer, neoadjuvant chemotherapy is still unique, because it renders curative surgery feasible for marginally resectable head and neck cancer patients. METHODS: We reviewed patients with locally advanced head and neck cancer, who had been treated with neoadjuvant chemotherapy between June 1984 and February 2001 at the Seoul National University Hospital. RESULTS: A total of 167 patients were included. After 2 to 3 chemotherapy cycles, either surgery (38 patients) or radiation (104 patients) was conducted. Those who received surgery exhibited better survival than those who received radiation [median survival: not reached vs 33.6 months (95% CI: 22.6-44.7), p = .006]. The 5-year and 10-year survival rates of surgery group were 63.2% and 59.8%. CONCLUSION: The potential benefit of neoadjuvant chemotherapy with surgery in patients with locally advanced head and neck cancers merits further evaluation in future clinical trials.


Subject(s)
Carcinoma/mortality , Carcinoma/therapy , Head and Neck Neoplasms/mortality , Head and Neck Neoplasms/therapy , Neoadjuvant Therapy , Adolescent , Adult , Aged , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Bleomycin/administration & dosage , Carboplatin/administration & dosage , Carcinoma/pathology , Cisplatin/administration & dosage , Etoposide/administration & dosage , Female , Fluorouracil/administration & dosage , Head and Neck Neoplasms/pathology , Humans , Male , Middle Aged , Mitomycin/administration & dosage , Prognosis , Radiotherapy, Adjuvant , Survival Analysis , Vincristine/administration & dosage
5.
Acta Otolaryngol Suppl ; (558): 121-7, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17882582

ABSTRACT

CONCLUSION: Pre-RT ND in patients with HNSCC undergoing organ preservation treatment is safe, advantageous, poses no additional morbidity owing to the elective neck dissection, and may possibly improve survival outcomes. OBJECTIVE: Establish the role of pre-radiation neck dissection (pre-RT ND) in patients with head & neck squamous cell carcinoma (HNSCC) undergoing organ preservation treatment. MATERIALS AND METHODS: Fourteen patients with histologically confirmed HNSCC in stages III approximately IV with proven regional metastasis were enrolled in the organ preservation approach incorporating pre-RT ND at a tertiary referral center between May 1998 and August 2004. Site matched patients treated with organ preservation intent in the conventional fashion were used as controls. Data were collected for their diagnosis, management, treatment outcome, and follow up. RESULTS: Disease free survival was significantly better for the pre-RT ND group. There was no significant difference in overall survival, pattern of recurrence, and primary organ preservation rate between the two groups. No significant morbidity owing to neck dissection was noted in patients who underwent neck dissection. Although the delivery of radiation to the primary site was delayed for patients in the pre-RT ND group, it did not influence the major outcomes.


Subject(s)
Carcinoma, Squamous Cell/mortality , Carcinoma, Squamous Cell/therapy , Head and Neck Neoplasms/mortality , Head and Neck Neoplasms/therapy , Neck Dissection , Radiotherapy, Adjuvant , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Bridged-Ring Compounds/administration & dosage , Carcinoma, Squamous Cell/pathology , Chemotherapy, Adjuvant , Cisplatin/administration & dosage , Disease-Free Survival , Female , Fluorouracil/administration & dosage , Head and Neck Neoplasms/pathology , Humans , Male , Middle Aged , Neoplasm Metastasis , Neoplasm Recurrence, Local/epidemiology , Radiotherapy Dosage , Taxoids/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL